Jaguar Gene Therapy
PrivateLast Round
Strategic
Mar 29, 2022
Total Funding Raised
$179M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Jaguar Gene Therapy operates in Healthcare & Life Sciences and is based in Lake Forest, Illinois. Its latest recorded funding round was a Strategic round in March 2022.
Jaguar Gene Therapy is a biotechnology company that develops gene therapy treatments to address severe genetic diseases by restoring gene function through the introduction of healthy gene copies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Jaguar Gene Therapy Comparables
Compare Jaguar Gene Therapy with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Capsida Biotherapeutics | 87% | |
| Latus Bio | 81% | |
| Roche Holding | 77% |
For institutional investors. Book with your work email.
Jaguar Gene Therapy Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Mar 29, 2022 | ||||
| Series B | Apr 13, 2021 | ||||
| Series A | Feb 25, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Jaguar Gene Therapy Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Deerfield Management | Series B, Series A |
| ARCH Venture Partners | Series B |
| Samsung Venture Investment | Strategic |
| JDRF | Strategic |
| Nolan Capital | Series B |
| Goldman Sachs | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 73% MoM, reaching 2.9K.
- Mar 29, 2022
Samsung Venture Investment led the strategic round.
For institutional investors. Book with your work email.
Jaguar Gene Therapy Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Jaguar Gene Therapy's valuation, stock price, and market status.
Is Jaguar Gene Therapy a public or private company?
Jaguar Gene Therapy is a private company.
What is the current stock price of Jaguar Gene Therapy?
Jaguar Gene Therapy is a private company, so its shares have no public market price. Caplight tracks Jaguar Gene Therapy's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Jaguar Gene Therapy worth (valuation)?
Valuation information for Jaguar Gene Therapy is not publicly available.
Can I buy Jaguar Gene Therapy stock?
Jaguar Gene Therapy shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Jaguar Gene Therapy's last funding round?
Jaguar Gene Therapy's most recent funding round was Strategic on March 29, 2022.
Who are the main investors in Jaguar Gene Therapy?
Key investors in Jaguar Gene Therapy include Deerfield Management, Samsung Venture Investment.
Will Jaguar Gene Therapy IPO soon?
No public IPO plans have been announced for Jaguar Gene Therapy.
How can I track Jaguar Gene Therapy secondary market activity?
Caplight tracks bids, offers, and trades in Jaguar Gene Therapy's shares on secondary markets.